Skip To Main Content
Lilly
Menu closed
Lilly
  • Medical Home
    • Medical Information
Chat Click to chat
Question Submit a question

Information Request

Lilly Rep Request

Expand contact lilly
Lilly

You are now leaving the Lilly Medical Web site

The link you clicked on will take you to a site maintained by a third party, which is solely responsible for its content. Eli Lilly and Company does not control, influence, or endorse this site, and the opinions, claims or comments expressed on this site should not be attributed to Eli Lilly and Company. Eli Lilly and Company is not responsible for the privacy policy of any third party web sites. We encourage you to read the privacy policy of every web site you visit.

  1. Medical Information Right
  2. Verzenios ® ▼ (abemaciclib) Right
  3. Should Verzenios® (abemaciclib) be paused before and held after surgery?
Search abemaciclib information
Search Medical Information


Tips for searching:

• You have to select a product and type at least 2 words to activate the search
• Use only words that are specific to the information you are looking for
• Avoid typing questions or sentences

Please do not use this field to report adverse events or product complaints. Adverse events and product complaints should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow card in the Google play or Apple app store. Adverse events and product complaints should also be reported to Lilly: please call Lilly UK on 01256 315 000.

Verzenios ® ▼ (abemaciclib)

This information is intended for UK registered healthcare professionals only as a scientific exchange in response to your search for information. For current prescribing information for all Lilly products, including Summaries of Product Characteristics, Patient Information Leaflets and Instructions for Use, please visit: www.medicines.org.uk (England, Scotland, Wales) or www.emcmedicines.com/en-GB/northernireland/ (Northern Ireland).

Should Verzenios® (abemaciclib) be paused before and held after surgery?

In the Monarch studies, abemaciclib was held at least 7 days before surgery and continued no earlier than 14 days after completion of surgery ± radiotherapy. In monarchE, abemaciclib was resumed after surgery as clinically indicated.

UK_cFAQ_ABE100_HOLDS_FOR_SURGERY
UK_cFAQ_ABE100_HOLDS_FOR_SURGERY
en-GB

Use of Abemaciclib During Invasive Procedures

Information on holding abemaciclib treatment for surgery is available in several clinical study protocols and is provided in this response. No additional information is available on the use of abemaciclib during invasive procedures or on the outcomes in patients who underwent surgery while on study.

Patients Undergoing Surgery in MONARCH 2 and MONARCH 3 

A patient with locally advanced (MONARCH 2) or locoregionally recurrent (MONARCH 3) breast cancer could receive surgery ± radiotherapy if study treatment rendered the tumor operable.1,2

Such a patient should not receive study treatment for the period beginning at least 7 days prior to surgery and continuing until at least 14 days after completion of surgery ± radiotherapy to allow for tissue healing and recovery.1,2